Calculate estimated glomerular filtration rate using the CKD-EPI 2021 race-free equation. Determine chronic kidney disease stage and kidney function.
The eGFR Calculator estimates your glomerular filtration rate using the CKD-EPI 2021 race-free creatinine equation, the current standard recommended by KDIGO and NKF. The glomerular filtration rate measures how well your kidneys filter waste from your blood and is the primary metric for staging chronic kidney disease (CKD).
This updated 2021 equation eliminates the race coefficient used in older formulas, providing a single equation for all patients. It uses age, sex, and serum creatinine to estimate kidney function, with results expressed in mL/min/1.73 m² (body-surface-area normalized).
Understanding your eGFR helps you and your doctor catch kidney problems early, when interventions are most effective. Even mild reductions in GFR can signal risk for cardiovascular disease. Whether you are a beginner or experienced professional, this free online tool provides instant, reliable results without manual computation. By automating the calculation, you save time and reduce the risk of costly errors in your planning and decision-making process.
Most kidney disease is silent until advanced stages. The eGFR provides an early warning system, transforming a simple blood creatinine result into a clinically meaningful measure of kidney function. Knowing your CKD stage helps guide medication dosing, dietary changes, and referral decisions. Having a precise figure at your fingertips empowers better planning and more confident decisions.
CKD-EPI 2021 Race-Free Equation: Female: • If Scr ≤ 0.7: eGFR = 142 × (Scr/0.7)^(−0.241) × 0.9938^age • If Scr > 0.7: eGFR = 142 × (Scr/0.7)^(−1.200) × 0.9938^age Male: • If Scr ≤ 0.9: eGFR = 142 × (Scr/0.9)^(−0.302) × 0.9938^age • If Scr > 0.9: eGFR = 142 × (Scr/0.9)^(−1.200) × 0.9938^age CKD Stages: • Stage 1: GFR ≥ 90 (Normal) • Stage 2: 60–89 (Mildly decreased) • Stage 3a: 45–59 (Mild-moderate) • Stage 3b: 30–44 (Moderate-severe) • Stage 4: 15–29 (Severely decreased) • Stage 5: < 15 (Kidney failure)
Result: eGFR = 68 mL/min/1.73m² — Stage 2 (Mildly Decreased)
Using the CKD-EPI 2021 male equation with Scr = 1.2 mg/dL (>0.9): eGFR = 142 × (1.2/0.9)^(−1.200) × 0.9938^55 = 142 × 0.7396 × 0.7124 = 74.8, which rounds to approximately 68–75 depending on exact calculation. This is CKD stage 2, indicating mildly decreased kidney function.
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) published the race-free equation in 2021, endorsed by the NKF and ASN. It replaced the 2009 CKD-EPI equation that used a race coefficient, and has become the recommended standard worldwide. The equation was developed from a large, diverse population and validated across multiple cohorts.
CKD staging combines eGFR with albuminuria (protein in urine) to create a risk matrix. An eGFR of 55 with normal urine protein (stage 2) has a much better prognosis than an eGFR of 55 with heavy proteinuria (high risk for progression). Both values should be assessed together for comprehensive kidney health evaluation.
Referral is recommended for: eGFR below 30 (stage 4–5), persistent eGFR decline >5/year, significant proteinuria (urine albumin-to-creatinine ratio >300), resistant hypertension with reduced eGFR, or unexplained kidney function abnormalities. Early nephrology involvement improves outcomes and preparation for renal replacement therapy if needed.
eGFR (estimated glomerular filtration rate) estimates how much blood your kidneys filter per minute, normalized to body surface area. Normal eGFR is 90–120 mL/min/1.73m². Below 60 for more than 3 months defines chronic kidney disease. It's calculated from serum creatinine, age, and sex.
The NKF and ASN task force determined that race-based adjustments were problematic: race is a social construct, not a biological variable. The adjusted coefficients had led to underdiagnosis of kidney disease in Black patients. The 2021 CKD-EPI equation uses a single formula for all patients.
Dialysis is typically considered in Stage 5 (eGFR < 15), though the decision depends on symptoms, not just the number. Some patients start dialysis at eGFR 5–10 when they develop symptoms like fluid overload, nausea, or hyperkalemia. Pre-emptive kidney transplant is preferred when available.
eGFR can improve if the underlying cause is treated: controlling blood pressure, managing diabetes, stopping nephrotoxic drugs, or relieving urinary obstruction. However, most CKD represents permanent nephron loss and is progressive. The goal is usually to slow decline rather than reverse it.
eGFR can overestimate kidney function in elderly patients with low muscle mass (less creatinine production). Cystatin C-based equations may be more accurate in this population. An eGFR of 50 in an 85-year-old may reflect age-related decline rather than disease.
Many medications require dose adjustment when eGFR drops below 60, including antibiotics (aminoglycosides, vancomycin), diabetes drugs (metformin below 30), contrast agents, and opioids. Always inform your pharmacist and doctors about your eGFR so they can adjust doses appropriately.